How Catryna Bilyk voted compared to someone who agrees that terminally ill people should be able to access medicinal cannabis products

Most important divisions relevant to this policy

These are the most important divisions related to the policy “for increasing access to medicinal cannabis products” which Catryna Bilyk could have attended. They are weighted much more strongly than other divisions when calculating the position of Catryna Bilyk on this policy.

Division Catryna Bilyk Supporters vote

13th Jun 2017, 1:10 PM – Senate Regulations and Determinations - Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016 - Disallow

absent Yes

11th May 2017 – Senate Regulations and Determinations - Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016 - Disallow

absent Yes

Other divisions relevant to this policy

These are less important divisions which are related to the policy “for increasing access to medicinal cannabis products” which Catryna Bilyk could have attended.

Division Catryna Bilyk Supporters vote

24th Nov 2022, 11:13 AM – Senate Narcotic Drugs (Licence Charges) Amendment Bill 2022 - Second Reading - Increase accessibility

No Yes

14th Nov 2019, 12:02 PM – Senate Committees - Community Affairs References Committee - Reference

absent Yes

13th Jun 2017, 1:04 PM – Senate Regulations and Determinations - Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016 - Vote on disallowance again

absent Yes

How "We can't say anything concrete about how they voted on" is worked out

Catryna Bilyk has only voted once on this policy and it wasn't on a "strong" vote. So it's not possible to draw a clear conclusion about their position.

This could be because there were simply not many relevant divisions (formal votes) during the time they've been in parliament (most votes happen on "the voices", so we simply have no decent record) or they were absent for votes that could have contributed to their voting record.